Literature DB >> 20699367

Insulin receptor A and IGF-1R in AML - Letter.

Nicolas Chapuis, Catherine Lacombe, Jerome Tamburini, Didier Bouscary, Patrick Mayeux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20699367     DOI： 10.1158/0008-5472.CAN-10-0136

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  3 in total

1.  Upregulation of IGF1R by mutant RAS in leukemia and potentiation of RAS signaling inhibitors by small-molecule inhibition of IGF1R.

Authors:  Ellen Weisberg; Atsushi Nonami; Zhao Chen; Erik Nelson; Yongfei Chen; Feiyang Liu; HaeYeon Cho; Jianming Zhang; Martin Sattler; Constantine Mitsiades; Kwok-Kin Wong; Qingsong Liu; Nathanael S Gray; James D Griffin
Journal:  Clin Cancer Res       Date:  2014-09-03       Impact factor: 12.531

2.  Peptide structure stabilization by membrane anchoring and its general applicability to the development of potent cell-permeable inhibitors.

Authors:  Liv Johannessen; Jarrett Remsberg; Vadim Gaponenko; Kristie M Adams; Joseph J Barchi; Sergey G Tarasov; Sheng Jiang; Nadya I Tarasova
Journal:  Chembiochem       Date:  2011-03-01       Impact factor: 3.164

3.  microRNA-628 inhibits the proliferation of acute myeloid leukemia cells by directly targeting IGF-1R.

Authors:  Lu Chen; Xin Jiang; Haoyue Chen; Qiaoyan Han; Chunhua Liu; Miao Sun
Journal:  Onco Targets Ther       Date:  2019-01-29       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.